230 related articles for article (PubMed ID: 36313987)
1. Design and analysis of umbrella trials: Where do we stand?
Ouma LO; Wason JMS; Zheng H; Wilson N; Grayling M
Front Med (Lausanne); 2022; 9():1037439. PubMed ID: 36313987
[TBL] [Abstract][Full Text] [Related]
2. An overview of precision oncology basket and umbrella trials for clinicians.
Park JJH; Hsu G; Siden EG; Thorlund K; Mills EJ
CA Cancer J Clin; 2020 Mar; 70(2):125-137. PubMed ID: 32031692
[TBL] [Abstract][Full Text] [Related]
3. Systematic review of basket trials, umbrella trials, and platform trials: a landscape analysis of master protocols.
Park JJH; Siden E; Zoratti MJ; Dron L; Harari O; Singer J; Lester RT; Thorlund K; Mills EJ
Trials; 2019 Sep; 20(1):572. PubMed ID: 31533793
[TBL] [Abstract][Full Text] [Related]
4. The future of Cochrane Neonatal.
Soll RF; Ovelman C; McGuire W
Early Hum Dev; 2020 Nov; 150():105191. PubMed ID: 33036834
[TBL] [Abstract][Full Text] [Related]
5. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
6. Master protocol trials in oncology: Review and new trial designs.
Hirakawa A; Asano J; Sato H; Teramukai S
Contemp Clin Trials Commun; 2018 Dec; 12():1-8. PubMed ID: 30182068
[TBL] [Abstract][Full Text] [Related]
7. Practical Considerations and Recommendations for Master Protocol Framework: Basket, Umbrella and Platform Trials.
Lu CC; Li XN; Broglio K; Bycott P; Jiang Q; Li X; McGlothlin A; Tian H; Ye J
Ther Innov Regul Sci; 2021 Nov; 55(6):1145-1154. PubMed ID: 34160785
[TBL] [Abstract][Full Text] [Related]
8. Master protocols and other innovative trial designs in inflammation and immunology to expedite clinical drug development.
Peeva E; Banerjee A; Banfield C; Soma K; Christensen J; Menon S; Vincent MS; Dolsten M
Drug Discov Today; 2024 May; 29(5):103948. PubMed ID: 38460567
[TBL] [Abstract][Full Text] [Related]
9. The Evolution of Master Protocol Clinical Trial Designs: A Systematic Literature Review.
Meyer EL; Mesenbrink P; Dunger-Baldauf C; Fülle HJ; Glimm E; Li Y; Posch M; König F
Clin Ther; 2020 Jul; 42(7):1330-1360. PubMed ID: 32622783
[TBL] [Abstract][Full Text] [Related]
10. New clinical trial designs in the era of precision medicine: An overview of definitions, strengths, weaknesses, and current use in oncology.
Janiaud P; Serghiou S; Ioannidis JPA
Cancer Treat Rev; 2019 Feb; 73():20-30. PubMed ID: 30572165
[TBL] [Abstract][Full Text] [Related]
11. Biostatistical and Logistical Considerations in the Development of Basket and Umbrella Clinical Trials.
Yee LM; McShane LM; Freidlin B; Mooney MM; Korn EL
Cancer J; 2019; 25(4):254-263. PubMed ID: 31335389
[TBL] [Abstract][Full Text] [Related]
12. Novel Study Designs in Precision Medicine - Basket, Umbrella and Platform Trials.
Ravi R; Kesari HV
Curr Rev Clin Exp Pharmacol; 2022; 17(2):114-121. PubMed ID: 34455953
[TBL] [Abstract][Full Text] [Related]
13. Reporting of master protocols towards a standardized approach: A systematic review.
Siden EG; Park JJ; Zoratti MJ; Dron L; Harari O; Thorlund K; Mills EJ
Contemp Clin Trials Commun; 2019 Sep; 15():100406. PubMed ID: 31334382
[TBL] [Abstract][Full Text] [Related]
14. Challenges, opportunities, and innovative statistical designs for precision oncology trials.
Yin J; Shen S; Shi Q
Ann Transl Med; 2022 Sep; 10(18):1038. PubMed ID: 36267789
[TBL] [Abstract][Full Text] [Related]
15. Umbrella and basket trials in oncology: ethical challenges.
Strzebonska K; Waligora M
BMC Med Ethics; 2019 Aug; 20(1):58. PubMed ID: 31443704
[TBL] [Abstract][Full Text] [Related]
16. Definitions and statistical properties of master protocols for personalized medicine in oncology.
Renfro LA; Mandrekar SJ
J Biopharm Stat; 2018; 28(2):217-228. PubMed ID: 28877008
[TBL] [Abstract][Full Text] [Related]
17. Unlocking the Potential: A Systematic Review of Master Protocol in Pediatrics.
Li Y; Nelson R; Izem R; Broglio K; Mundayat R; Gamalo M; Wen Y; Pan H; Sun H; Ye J
Ther Innov Regul Sci; 2024 Jul; 58(4):634-644. PubMed ID: 38653950
[TBL] [Abstract][Full Text] [Related]
18. Current usage and challenges of master protocols-based on survey results by ASA BIOP oncology methodology working group master protocol sub-team.
Li X; Lu C; Broglio K; Bycott P; Chen J; Jiang Q; Lin J; Ye J; Yin J
Ann Transl Med; 2022 Sep; 10(18):1036. PubMed ID: 36267733
[TBL] [Abstract][Full Text] [Related]
19. Biomarker-Driven Oncology Clinical Trials: Novel Designs in the Era of Precision Medicine.
Moore DC; Guinigundo AS
J Adv Pract Oncol; 2023 Apr; 14(Suppl 1):9-13. PubMed ID: 37206904
[TBL] [Abstract][Full Text] [Related]
20. Efficacy and safety of levetiracetam in children with epilepsy: protocol for an umbrella review of systematic reviews and meta-analyses of randomised controlled trials.
Gan J; Ma D; Xiong T
BMJ Open; 2019 Jul; 9(7):e029811. PubMed ID: 31296513
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
